Hall Julie M, Korach Kenneth S
Receptor Biology Section, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 2002 Nov 15;277(46):44455-61. doi: 10.1074/jbc.M200849200. Epub 2002 Aug 27.
Most of the currently available information on the transcriptional activities of endocrine-disrupting chemicals (xenoestrogens) through estrogen receptors alpha (ERalpha) and beta (ERbeta) has been derived from transactivation studies on synthetic estrogen-responsive reporters. Thus, the ability of the xenoestrogen-liganded ERs to regulate endogenous estrogen-responsive gene expression has not been well characterized. Here, we have evaluated the activities of xenoestrogens through ERalpha and ERbeta on the vitellogenin A2 estrogen-response element (ERE) and the human pS2, lactoferrin, and complement 3 physiological target gene promoters. Using mammalian cell transient transfection assays, we found that the activities of xenoestrogens were mediated in a promoter-specific manner. For example, when bound to all ligands examined, ERalpha displayed high levels of transcription on the vitellogenin ERE and the lactoferrin promoter, but substantially lower activity on the complement 3 and pS2 promoters. However, one of the most important observations was that there were significant differences in the relative transcriptional activities of xenoestrogen-bound ERalpha and ERbeta on different promoters, suggesting that ERalpha and ERbeta make unique contributions to xenoestrogen action in target cells. When probing the molecular mechanism of the promoter-specific activities observed, we found that the transcriptional activity of the ERs correlated with the ability of each receptor to assume an active conformation on specific promoters. Taken together, the results indicate that the transcriptional activities of xenoestrogens are mediated in a promoter-specific manner and that estrogen-responsive promoters communicate differently with ERalpha and ERbeta by influencing their structures in a distinct manner that leads to diversity in their transcriptional responses.
目前关于内分泌干扰化学物质(异雌激素)通过雌激素受体α(ERα)和β(ERβ)发挥转录活性的大部分现有信息,都来自对合成雌激素反应性报告基因的反式激活研究。因此,异雌激素配体结合的雌激素受体调节内源性雌激素反应性基因表达的能力尚未得到充分表征。在此,我们评估了异雌激素通过ERα和ERβ对卵黄蛋白原A2雌激素反应元件(ERE)以及人pS2、乳铁蛋白和补体3生理靶基因启动子的活性。使用哺乳动物细胞瞬时转染试验,我们发现异雌激素的活性以启动子特异性方式介导。例如,当与所有检测的配体结合时,ERα在卵黄蛋白原ERE和乳铁蛋白启动子上显示出高水平的转录,但在补体3和pS2启动子上的活性则显著较低。然而,最重要的观察结果之一是,异雌激素结合的ERα和ERβ在不同启动子上相对转录活性存在显著差异,这表明ERα和ERβ在靶细胞的异雌激素作用中发挥独特作用。在探究所观察到的启动子特异性活性的分子机制时,我们发现雌激素受体的转录活性与每个受体在特定启动子上呈现活性构象的能力相关。综上所述,结果表明异雌激素的转录活性以启动子特异性方式介导,并且雌激素反应性启动子通过以不同方式影响其结构从而导致转录反应的多样性,与ERα和ERβ进行不同的交流。